Clinical Trial Update: Base Edited CAR T Cells Against AML: Deep Conditioning Ahead of Allogeneic Stem Cell Transplantation [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating base-edited CAR T cells in relapsed acute myeloid leukemia, with deep conditioning ahead of allogeneic stem cell transplantati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Base Edited CAR T cells (Base-edited CAR T cells)

Snippet

Sponsor: Great Ormond Street Hospital for Children NHS Foundation Trust | Conditions: Relapsed Acute Myeloid Leukaemia | Phase 1 | Status: ACTIVE_NOT_RECRUITING